SEARCH

SEARCH BY CITATION

REFERENCES

  • Alexander WS. (1949) Progressive fibrinoid degeneration of fibrillary astrocytes associated with mental retardation in a hydrocephalic infant. Brain 72:373381.
  • Armstrong BK, Smith QR, Rapoport SI, Strohalm J, Kopacek J, Duncan R. (1989) Osmotic opening of the blood-brain barrier permeability to N-(2-hydroxypropyl) methacrylamide copolymers. Effects of polymer m.w., charge and hydrophobicity. Journal of Controlled Release 10:2735.
  • Clancy RR, Sharif U, Ichord R, Spray TL, Nicolson S, Tabbutt S, Wernovsky G, Gaynor JW. (2005) Electrographic neonatal seizures after infant heart surgery. Epilepsia 46:8490.
  • Fazio V, Bhudia SK, Marchi N, Aumayr B, Janigro D. (2004) Peripheral detection of S100beta during cardiothoracic surgery: what are we really measuring?The Annals of Thoracic Surgery 78:4652.
  • Fieschi C, Lenzi GL, Zanette E, Orzi F, Passero S. (1980) Effects on EEG of the osmotic opening of the blood-brain barrier in rats. Life Sciences 27:239243.
  • Frey LC. (2003) Epidemiology of posttraumatic epilepsy: a critical review. Epilepsia 44(suppl. 10):1117.
  • Gaynor JW, Nicolson SC, Jarvik GP, Wernovsky G, Montenegro LM, Burnham NB, Hartman DM, Louie A, Spray TL, Clancy RR. (2005) Increasing duration of deep hypothermic circulatory arrest is associated with an increased incidence of postoperative electroencephalographic seizures. The Journal of Thoracic and Cardiovascular Surgery 130:12781286.
  • Grant GA, Janigro D. (2004) The blood-brain barrier. In WinnHR (Ed) Youmans neurological surgery. Saunders, Philadelphia , PA , pp. 153174.
  • Greig NH, Daly EM, Sweeney DJ, Rapoport SI. (1990) Pharmacokinetics of chlorambucil-tertiary butyl ester, a lipophilic chlorambucil derivative that achieves and maintains high concentrations in brain. Cancer Chemotherapy and Pharmacology 25:320325.
  • Haglund MM, Hochman DW. (2005) Furosemide and mannitol suppression of epileptic activity in the human brain. Journal of Neurophysiology 94:907918.
  • Janigro D. (1999) Blood-brain barrier, ion homeostasis and epilepsy: possible implications towards the understanding of ketogenic diet mechanisms. Epilepsy Research 37:223232.
  • Jaranyi Z, Szekely M, Bobek I, Galfy I, Geller L, Selmeci L. (2003) Impairment of blood-brain barrier integrity during carotid surgery as assessed by serum S-100B protein concentrations. Clinical Chemistry and Laboratory Medicine 41:13201322.
  • Kapural M, Krizanac-Bengez L, Barnett G, Perl J, Masaryk T, Apollo D, Rasmussen P, Mayberg MR, Janigro D. (2002) Serum S-100beta as a possible marker of blood-brain barrier disruption. Brain Research 940:102104.
  • Korn A, Golan H, Melamed I, Pascual-Marqui R, Friedman A. (2005) Focal cortical dysfunction and blood-brain barrier disruption in patients with Postconcussion syndrome. Journal of Clinical Neurophysiology 22:19.
  • Kroll RA, Neuwelt EA. (1998) Outwitting the blood-brain barrier for therapeutic purposes: osmotic opening and other means. Neurosurgery 42:10831099.
  • Li R, Johnson AB, Salomons G, Goldman JE, Naidu S, Quinlan R, Cree B, Ruyle SZ, Banwell B, D'Hooghe M, Siebert JR, Rolf CM, Cox H, Reddy A, Gutierrez-Solana LG, Collins A, Weller RO, Messing A, Van Der Knaap MS, Brenner M. (2005) Glial fibrillary acidic protein mutations in infantile, juvenile, and adult forms of Alexander disease. Annals of Neurology 57:310326.
  • Marchi N, Cavaglia M, Bhudia S, Hallene K, Janigro D. (2004) Peripheral markers of blood-brain barrier damage. Clinica Chimica Acta 342:112.
  • Marchi N, Fazio V, Cucullo L, Kight K, Masary KT, Barnett G, Vogelbaum M, Kinter M, Rasmussen P, Mayberg MR, Janigro D. (2003a) Serum transthyretin as a possible marker of blood-to-CSF barrier disruption. Journal of Neuroscience 23:19491955.
  • Marchi N, Rasmussen PA, Kapural M, Fazio V, Cavaglia M, Janigro D. (2003b) Peripheral markers of brain damage and blood-brain barrier dysfunction. Restorative Neurology and Neuroscience 21:109121.
  • Mignot C, Boespflug-Tanguy O, Gelot A, Dautigny A, Pham-Dinh D, Rodriguez D. (2004) Alexander disease: putative mechanisms of an astrocytic encephalopathy. Cellular and Molecular Life Sciences 61:369385.
  • Mussack T, Biberthaler P, Geisenberger T, Gippner-Steppert C, Steckmeier B, Mutschler W, Jochum M. (2002) Assessment of early brain damage in carotid endarterectomy: evaluation of S-100B serum levels and somatosensory evoked potentials in a pilot study. World Journal of Surgery 26:12511255.
  • Naing A, Luong D, Extermann M. (2005) Methotrexate-induced status epilepticus. American Journal of Hematology 80:3537.
  • Neuwelt EA, Glasberg M, Frenkel E, Barnett P. (1983a) Neurotoxicity of chemotherapeutic agents after blood-brain barrier modification: neuropathological studies. Annals of Neurology 14:316324.
  • Neuwelt EA, Goldman DL, Dahlborg SA, Crossen J, Ramsey F, Roman-Goldstein S, Braziel R, Dana B. (1991) Primary CNS lymphoma treated with osmotic blood-brain barrier disruption: prolonged survival and preservation of cognitive function. Journal of Clinical Oncology 9:15801590.
  • Neuwelt EA, Specht HD, Howieson J, Haines JE, Bennett MJ, Hill SA, Frenkel EP. (1983b) Osmotic blood-brain barrier modification: clinical documentation by enhanced CT scanning and/or radionuclide brain scanning. AJR American Journal of Roentgenology 141:829835.
  • Newburger JW, Jonas RA, Wernovsky G, Wypij D, Hickey PR, Kuban KC, Farrell DM, Holmes GL, Helmers SL, Constantinou J. (1993) A comparison of the perioperative neurologic effects of hypothermic circulatory arrest versus low-flow cardiopulmonary bypass in infant heart surgery. The New England Journal of Medicine 329:10571064.
  • Pekny M, Stanness KA, Eliasson C, Betsholtz C, Janigro D. (1998) Impaired induction of blood-brain barrier properties in aortic endothelial cells by astrocytes from GFAP-deficient mice. Glia 22:390400.
  • Phillips PC, Dhawan V, Strother SC, Sidtis JJ, Evans AC, Allen JC, Rottenberg DA. (1987) Reduced cerebral glucose metabolism and increased brain capillary permeability following high-dose methotrexate chemotherapy: a positron emission tomographic study. Annals of Neurology 21:5963.
  • Roman-Goldstein S, Clunie DA, Stevens J, Hogan R, Monard J, Ramsey F, Neuwelt EA. (1994a) Osmotic blood-brain barrier disruption: CT and radionuclide imaging. AJNR American Journal of Neuroradiology 15:581590.
  • Roman-Goldstein SM, Barnett PA, McCormick CI, Ball MJ, Ramsey F, Neuwelt EA. (1991) Effects of gadopentetate dimeglumine administration after osmotic blood- brain barrier disruption: toxicity and MR imaging findings. AJNR American Journal of Neuroradiology 12:885890.
  • Roman-Goldstein SM, Barnett PA, McCormick CI, Szumowski J, Shannon EM, Ramsey FL, Mass M, Neuwelt EA. (1994b) Effects of Gd-DTPA after osmotic BBB disruption in a rodent model: toxicity and MR findings. Journal of Computer Assisted Tomography 18:731736.
  • Schmidt RH, Grady MS. (1993) Regional patterns of blood-brain barrier breakdown following central and lateral fluid percussion injury in rodents. Journal of Neurotrauma 10:415430.
  • Schwartzkroin PA, Baraban SC, Hochman DW. (1998) Osmolarity, ionic flux, and changes in brain excitability. Epilepsy Research 32:275285.
  • Seiffert E, Dreier JP, Ivens S, Bechmann I, Tomkins O, Heinemann U, Friedman A. (2004) Lasting blood-brain barrier disruption induces epileptic focus in the rat somatosensory cortex. Journal of Neuroscience 24:78297836.
  • Sendrowski K, Sobaniec W, Sobaniec-Lotowska ME, Lewczuk P. (2004) S-100 protein as marker of the blood-brain barrier disruption in children with internal hydrocephalus and epilepsy–a preliminary study. Roczniki Akademii Medycznej w Białymstoku 49(suppl. 1):236238.
  • Shiihara T, Kato M, Honma T, Ohtaki S, Sawaishi Y, Hayasaka K. (2002) Fluctuation of computed tomographic findings in white matter in Alexander's disease. Journal of Child Neurology 17:227230.
  • Vogelbaum MA, Masaryk T, Mazzone P, Mekhail T, Fazio V, McCartney S, Marchi N, Kanner A, Janigro D. (2005) S100beta as a predictor of brain metastases: brain versus cerebrovascular damage. Cancer 104:817824.